Edwards Lifesciences Corp
EW
Revenue
1.39B
▼-212.30M▼-13.28%
3 Months ChangeAssets
10.10B
▲363.00M▲3.73%
3 Months ChangeLiabilities
2.59B
▲44.80M▲1.76%
3 Months ChangeFree Cash Flow
-118.80M
▼-371.40M▼-147.03%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001099800-24-000084
2024-09-03
Form 8-K
ID: 0001099800-24-000082
2024-07-31
Form 10-Q
ID: 0001099800-24-000078
2024-07-24
Form 8-K
ID: 0001099800-24-000069
2024-07-15
Form 8-K
ID: 0001099800-24-000066
2024-07-10
Form 8-K
ID: 0001099800-24-000061
2024-06-17
Form 8-K
ID: 0001099800-24-000054
2024-06-03
Form 8-K
ID: 0001193125-24-152323
2024-05-08
Form 8-K
ID: 0001099800-24-000045
2024-04-29
Form 10-Q
ID: 0001099800-24-000039